BIOD

Biodel Inc. News Headlines

$1.46
*  
0.08
5.8%
Get BIOD Alerts
*Delayed - data as of Jan. 23, 2015  -  Find a broker to begin trading BIOD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Will Novartis' (NVS) Earnings Disappoint Expectations in Q4? - Analyst Blog
1/23/2015 5:50:00 PM - Zacks.com


Will Novartis' (NVS) Earnings Disappoint Expectations in Q4? - Analyst Blog
1/23/2015 5:50:00 AM - Investopedia


UCB's New Epilepsy Drug Under Review in the U.S., EU - Analyst Blog
1/22/2015 7:00:00 PM - Zacks.com


UCB's New Epilepsy Drug Under Review in the U.S., EU - Analyst Blog
1/22/2015 7:00:00 AM - Investopedia


Valeant's Bausch + Lomb Imaging System Cleared by FDA - Analyst Blog
1/21/2015 5:35:00 PM - Zacks.com


CytRx Relieved as FDA Lifts Partial Hold on Oncology Drug - Analyst Blog
1/21/2015 4:15:00 PM - Zacks.com


ARIAD's Iclusig Endorsed by EC for All Approved Indications - Analyst Blog
1/21/2015 2:00:00 PM - Investopedia


ARIAD's Iclusig Endorsed by EC for All Approved Indications - Analyst Blog
1/21/2015 2:00:00 PM - Zacks.com


Valeant's Bausch + Lomb Imaging System Cleared by FDA - Analyst Blog
1/21/2015 5:35:00 AM - Investopedia


CytRx Relieved as FDA Lifts Partial Hold on Oncology Drug - Analyst Blog
1/21/2015 4:15:00 AM - Investopedia


Immunomedics Reports Data on Oncology Candidate - Analyst Blog
1/21/2015 4:05:00 AM - Investopedia


Novo Nordisk's Xultophy to Launch First in Switzerland - Analyst Blog
1/20/2015 2:10:00 PM - Investopedia


Novo Nordisk's Xultophy to Launch First in Switzerland - Analyst Blog
1/20/2015 2:10:00 PM - Zacks.com


UCB-Neuropore Collaborate for Parkinson's Disease Therapy - Analyst Blog
1/19/2015 2:10:00 PM - Investopedia


UCB-Neuropore Collaborate for Parkinson's Disease Therapy - Analyst Blog
1/19/2015 2:10:00 PM - Zacks.com


Sarepta Starts Dosing in Duchenne Muscular Dystrophy Study - Analyst Blog
1/15/2015 4:30:00 PM - Zacks.com


Regado Biosciences to Merge with Tobira Therapeutics - Analyst Blog
1/15/2015 2:30:00 PM - Investopedia


Regado Biosciences to Merge with Tobira Therapeutics - Analyst Blog
1/15/2015 2:30:00 PM - Zacks.com


Sarepta Starts Dosing in Duchenne Muscular Dystrophy Study - Analyst Blog
1/15/2015 4:30:00 AM - Investopedia


Shire to Acquire NPS Pharmaceuticals for $5.2B - Analyst Blog
1/12/2015 5:48:00 PM - Zacks.com


Shire to Acquire NPS Pharmaceuticals for $5.2B - Analyst Blog
1/12/2015 5:48:00 AM - Investopedia


Valeant Up on Better-than-Expected 2015 Outlook, Eyes Deals - Analyst Blog
1/9/2015 5:50:00 PM - Zacks.com


Infinity Pharmaceuticals Falls on Duvelisib Study Results - Analyst Blog
1/9/2015 5:00:00 PM - Zacks.com


Pacira Q4 & 2014 Revenues to Come In Line with Estimates - Analyst Blog
1/9/2015 4:20:00 PM - Zacks.com


Valeant Up on Better-than-Expected 2015 Outlook, Eyes Deals - Analyst Blog
1/9/2015 5:50:00 AM - Investopedia